破骨细胞
兰克尔
骨溶解
基质金属蛋白酶
化学
肿瘤微环境
癌症研究
骨吸收
骨重建
肿瘤进展
MMP1型
病理
生物
内分泌学
内科学
医学
癌症
肿瘤细胞
受体
生物化学
激活剂(遗传学)
基因表达
外科
基因
作者
Sophie Thiolloy,Jennifer L. Halpern,Ginger E. Holt,Herbert S. Schwartz,Gregory R. Mundy,Lynn McCormick Matrisian,Conor C. Lynch
出处
期刊:Cancer Research
[American Association for Cancer Research]
日期:2009-08-12
卷期号:69 (16): 6747-6755
被引量:72
标识
DOI:10.1158/0008-5472.can-08-3949
摘要
The matrix metalloproteinases MMP-2, MMP-3, MMP-7, MMP-9, and MMP-13 are highly expressed in the tumor-bone microenvironment, and, of these, MMP-7 and MMP-9 were found to be localized to bone-resorbing osteoclasts in human breast-to-bone metastases. In a bid to define the roles of host-derived MMP-7 and MMP-9 in the tumor-bone microenvironment, the tibias of MMP-7 and MMP-9 null mice were injected with osteolytic luciferase-tagged mammary tumor cell lines. Our data show that osteoclast-derived MMP-7 significantly contributes to tumor growth and tumor-induced osteolysis whereas osteoclast-derived MMP-9 had no effect on these processes. MMP-7 is capable of processing a number of nonmatrix molecules to soluble active forms that have profound effects on cell-cell communication, such as RANKL, a crucial mediator of osteoclast precursor recruitment and maturation. Therefore, the ability of osteoclast-derived MMP-7 to promote RANKL solubilization in the tumor-bone microenvironment was explored. Results revealed that levels of soluble RANKL were significantly lower in the MMP-7 null mice compared with wild-type (WT) controls. In keeping with this observation, MMP-7 null mice had significantly fewer osteoclast numbers at the tumor-bone interface compared with the WT controls. In summary, we propose that the solubilization of RANKL by MMP-7 is a potential mechanism through which MMP-7 mediates mammary tumor-induced osteolysis. Our studies indicate that the selective inhibition of MMP-7 in the tumor-bone microenvironment may be of benefit for the treatment of lytic breast-to-bone metastases.
科研通智能强力驱动
Strongly Powered by AbleSci AI